Abstract
Purpose
To evaluate the effects of a synbiotic substance on the vitamin D (VitD) status of elderly, and its association with systemic inflammation. Research question: Is synbiotic supplementation able to improve the VitD status?
Methods
This is a secondary study from a randomized, parallel, double-blind controlled clinical trial, lasting 24 weeks, with 49 participants randomly assigned into two groups; the S-group received a synbiotic substance, and the P-group received placebo. Participants were evaluated at baseline and at the end of the study for body fat percentage (% fat); plasma levels of interleukin-10 (IL-10) and interleukin-6 (IL-6), obtaining the IL-10/IL-6 ratio, named anti-inflammatory index (AII); plasma markers of gut permeability; and plasma VitD concentration.
Results
None of the variables investigated presented significant differences between groups. However, the delta-value of VitD showed to be positive in S-group (which means that in average, this group increased this variable), while the delta value was reduced in S-group. The same behavior was observed with the AII values. From regression models, only the AII explained positively and significantly the final value of VitD.
Conclusions
We did not find significant effect of synbiotic supplementation on VitD status in community-dwelling elderly; the biomarkers of systemic inflammation explained the final values of VitD. Several uncertainties were observed in our study, especially regarding the ideal marker of gut permeability and the ideal measure of VitD. More studies are needed before drawing definitive conclusions.
Similar content being viewed by others
Abbreviations
- %Fat:
-
body fat percentage
- AII:
-
anti-inflammatory index
- CAPES :
-
Coordination for the Improvement of Higher Education Personnel
- CFU:
-
colony forming unit
- DEXA:
-
dual-energy X-ray absorptiometry
- FAPESP:
-
São Paulo Research Foundation
- FM:
-
body fat mass
- FOS:
-
fructooligosaccharide
- HPLC:
-
high-performance liquid chromatography
- iFABP:
-
intestinal fatty-acid binding protein
- IL-10:
-
interleukin-10
- IL-6:
-
interleukin-6
- LPS:
-
lipopolysaccharide
- NF:
-
nuclear factor
- P:
-
group- placebo group
- REBEC:
-
Brazilian Registration of Clinical Studies
- S-group:
-
synbiotic group
- SR:
-
systematic review
- VDR:
-
vitamin D receptor
- VitD:
-
Vitamin D (25OH)D3
- VitDfin :
-
final values of VitD
- VitDin :
-
initial values of VitD
- Δ-value:
-
delta-value (difference between final and baseline results)
References
Chen Y, Du J, Zhang Z, Liu T, Shi Y, Ge X, et al. MicroRNA-346 mediates tumor necrosis factor alpha-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:1910–8.
Matyjaszek-Matuszek B, Lenart-Lipińska M, Woźniakowska E. Clinical implications of vitamin D deficiency. Prz Menopauzalny. 2015;14:75–81.
Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl). 2010;88:441–50.
Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423–32.
Yoon SS, Sun J. Probiotics, nuclear receptor signaling, and anti-inflammatory pathways (2011). Gastroenterol Res Pract. 2011;971938. https://doi.org/10.1155/2011/971938.
Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69:S4–9.
Franceschi C, Bonafé M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamma-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54.
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128:92–105.
Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, et al. Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp. 2016;64:111–26.
Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev. 2010;31:817–44.
Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012;142:1100–1.
Kamada N, Chen GY, Inohara N, Nuñez G. Control of pathogens and pathobionts by the gut microbiota. Nature Immunology. 2013;14:685–90.
Bakke D, Chatterjee I, Agrawal A, Dai Y, Sun J (2018). Regulation of microbiota by vitamin D receptor: a nuclear weapon in metabolic diseases. Nucl receptor res. 2018;pii: 101377.
Magrone T, Russo MA, Jirillo E. Role of immune cells in the course of central nervous system injury: modulation with natural products. Curr Pharm Des. 2016;22:701–8.
Melo AD, Silveira H, Luciano FB, Andrade C, Costa LB, Rostagno MH. Intestinal alkaline phosphatase: potential roles in promoting gut health in weanling piglets and its modulation by feed additives - a review. Asian-Australas J Anim Sci. 2016;29:16–22.
Carvalho CMR, Ribeiro SML. Aging, low-grade systemic inflammation and vitamin D. A mini-review Eur J Clin Nutr. 2017;71:434–40.
Douglas LC, Sanders ME. Probiotics and prebiotics in dietetics practice. J Am Diet Assoc. 2008;108:510–21.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.
Cohen J. Statistical power analysis for the behavior sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
Neto JV, de Melo CM, Ribeiro SM. Effects of three-month intake of synbiotic on inflammation and body composition in the elderly: a pilot study. Nutrients. 2013;5:1276–86.
Dirks NF, Ackermans MT, Lips P, de Jongh RT, Vervloet MG, de Jonge R, Heijboer AC (2018). The when, what & how of measuring vitamin D metabolism in clinical medicine. Nutrients 10(4). Pii: E482.
Tirang R, Neyestani AG, Kalayi A. Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res. 2007;77:341–6.
Laird E, Mcnulty H, Ward M, Hoev L, Mcsorlev E, Wallace JM, et al. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrin Metab. 2014;99:1807–15.
Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285:2227–31.
Silva MC, Furlanetto TW. Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr Res. 2015;35:91–6.
Galipeau HJ, Verdu EF. The complex task of measuring intestinal permeability in basic and clinical science. Neurogastroenterol Motil. 2016;28:957–65.
Derikx JP, Luyer MD, Heineman E, Buurman WA. Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol. 2010;16:5272–9.
Song WB, Lv YH, Zhang ZS, Li YN, Xiao LP, Yu XP, et al. Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease. World J Gastroenterol. 2009;15:3916–9.
Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods. 2015;421:44–53.
Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg. 2010;2:61–9.
Drincic AT, Armas LA, Vand Diest EE, Heaney RR. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444–8.
Yiu JH, Dorweiler B, Woo CW. Interaction between gut microbiota and toll-like receptor: from immunity to metabolism. J Mol Med (Berl). 2017;95(1):13–20.
Acknowledgements
The supplements used in this experiment were donated by Invictus-Farmanutrição® exclusively for research purposes. We thank to Nicola A.C. Zorzetto, for the English review. The authors acknowledge the help of the students João Valentini Neto and Angelica M. de Pina Freitas in data collection.
Funding
The authors thank the Coordination for the Improvement of Higher Education Personnel (CAPES) - (Protocol no. 06/2011-Casadinho-PROCAD), and São Paulo Research Foundation (FAPESP) – Research Project no. 2012/15976-0.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical standards
This study been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments; in addition, the study was approved by the Local Ethics in Human Research Committee (Process 200.870/2013). The procedures and the aim of the study were explained to the participants. While all the subjects were informed of the importance of remaining in the study for the entire 6 months, they were reassured of their right to withdraw from the study at any time. After the explanations, all the volunteers gave their informed consent prior to their inclusion in the study.
Rights and permissions
About this article
Cite this article
de Carvalho, C.M.R.G., Luzia, L.A., Rondó, P.H. et al. Associations between vitamin D, systemic inflammation and synbiotic supplementation: secondary study from a randomized clinical trial. Nutrire 45, 4 (2020). https://doi.org/10.1186/s41110-019-0104-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s41110-019-0104-7